REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 14th, 2018 • Artelo Biosciences, Inc. • Services-business services, nec
Contract Type FiledSeptember 14th, 2018 Company IndustryThis Agreement is made pursuant to the Subscription Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Subscription Agreement”).
SUBSCRIPTION AGREEMENTSubscription Agreement • September 14th, 2018 • Artelo Biosciences, Inc. • Services-business services, nec • New York
Contract Type FiledSeptember 14th, 2018 Company Industry JurisdictionIn connection with the purchase by the undersigned of Units of the Company, the undersigned is delivering this representation letter to the Subscription Agreement between the undersigned and the Company, the undersigned hereby represents, warrants and certifies to the Company that the undersigned is resident in British Columbia or is otherwise subject to the securities laws of British Columbia, and is either (A) an “accredited investor” within the meaning National Instrument 45-106 (Prospectus and Registration Exemptions) on the basis that the undersigned fits within that category of “accredited investor” identified on the attached Schedule to this Representation Letter beside which the undersigned has marked its initials; or (B) is purchasing the Units as a principal, and is (please initial all applicable descriptions):
ARTELO BIOSCIENCES, INC. SERIES C COMMON STOCK PURCHASE WARRANTSubscription Agreement • September 14th, 2018 • Artelo Biosciences, Inc. • Services-business services, nec • New York
Contract Type FiledSeptember 14th, 2018 Company Industry JurisdictionIn connection with the purchase by the undersigned of Units of the Company, the undersigned is delivering this representation letter to the Subscription Agreement between the undersigned and the Company, the undersigned hereby represents, warrants and certifies to the Company that the undersigned is resident in British Columbia or is otherwise subject to the securities laws of British Columbia, and is either (A) an “accredited investor” within the meaning National Instrument 45-106 (Prospectus and Registration Exemptions) on the basis that the undersigned fits within that category of “accredited investor” identified on the attached Schedule to this Representation Letter beside which the undersigned has marked its initials; or (B) is purchasing the Units as a principal, and is (please initial all applicable descriptions):